Tim Hirsch questioned
GBIF is currently prioritizing mobilization of occurrence data relating to vectors, hosts and reservoirs of zoonotic diseases. Even with current gaps, open-access biodiversity data is already used in many studies to evaluate disease spillover risk areas and other research relating to human health and climate change. Does the panel agree that increased biodiversity data sharing is an important component of improved understanding of disease risks and will help to target surveillance programmes?